| 1 | APOC3, MDM2
|
| Mdm2 is a novel activator of ApoCIII promoter which is antagonized by p53 and SHP inhibition.
|
| Yang Z, Zhang Y, Wang L.
|
| Biochem Biophys Res Commun 417(2):744-6. Epub 2011 Dec 16.
2012
|
| 2 | APOC3
|
| Association of lipoprotein lipase and apolipoprotein C-III genes polymorphism with acute myocardial infarction in diabetic patients.
|
| Abd El-Aziz TA, Mohamed RH, Hashem RM.
|
| Mol Cell Biochem 354(1-2):141-50. Epub 2011 Apr 17.
2011
|
| 3 | APOC3
|
| Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease.
|
| Ooi EM, Chan DT, Watts GF, Chan DC, Ng TW, Dogra GK, Irish AB, Barrett PH.
|
| J Lipid Res 52(4):794-800. Epub 2011 Feb 6.
2011
|
| 4 | APOC3
|
| Transcriptional activation of apolipoprotein CIII expression by glucose may contribute to diabetic dyslipidemia.
|
| Caron S, Verrijken A, Mertens I, Samanez CH, Mautino G, Haas JT, Duran-Sandoval D, Prawitt J, Francque S, Vallez E, Muhr-Tailleux A, Berard I, Kuipers F, Kuivenhoven JA, Biddinger SB, Taskinen MR, Van Gaal L, Staels B.
|
| Arterioscler Thromb Vasc Biol 31(3):513-9. Epub 2010 Dec 23.
2011
|
| 5 | APOC3
|
| Lowering apolipoprotein CIII delays onset of type 1 diabetes.
|
| Holmberg R, Refai E, Höög A, Crooke RM, Graham M, Olivecrona G, Berggren PO, Juntti-Berggren L.
|
| Proc Natl Acad Sci U S A 108(26):10685-9. Epub 2011 Jun 13.
2011
|
| 6 | APOC3, PPARGC1B
|
| Regulation of hepatic ApoC3 expression by PGC-1β mediates hypolipidemic effect of nicotinic acid.
|
| Hernandez C, Molusky M, Li Y, Li S, Lin JD.
|
| Cell Metab 12(4):411-9.
2010
|
| 7 | APOC3
|
| Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype.
|
| Zheng C, Khoo C, Furtado J, Sacks FM.
|
| Circulation 121(15):1722-34. Epub 2010 Apr 5.
2010
|
| 8 | APOA5, APOC3
|
| Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome.
|
| Niculescu LS, Vlădică M, Sima AV.
|
| Biochem Biophys Res Commun 391(1):587-91. Epub 2009 Nov 20.
2010
|
| 9 | APOC3
|
| ApoC-III gene expression is sharply increased during adipogenesis and is augmented by retinoid X receptor (RXR) agonists.
|
| Takahashi Y, Inoue J, Kagechika H, Sato R.
|
| FEBS Lett 583(2):493-7. Epub 2008 Dec 31.
2009
|
| 10 | APOC3
|
| A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection.
|
| Pollin TI, Damcott CM, Shen H, Ott SH, Shelton J, Horenstein RB, Post W, McLenithan JC, Bielak LF, Peyser PA, Mitchell BD, Miller M, O'Connell JR, Shuldiner AR.
|
| Science 322(5908):1702-5.
2008
|
| 11 | APOC3, TLR2
|
| Toll-like receptor 2 mediates apolipoprotein CIII-induced monocyte activation.
|
| Kawakami A, Osaka M, Aikawa M, Uematsu S, Akira S, Libby P, Shimokado K, Sacks FM, Yoshida M.
|
| Circ Res 103(12):1402-9. Epub 2008 Oct 30.
2008
|
| 12 | APOA1, APOA2, APOB, APOC1, APOC2, APOC3, APOE, CLU
|
| Apolipoprotein localization in isolated drusen and retinal apolipoprotein gene expression.
|
| Li CM, Clark ME, Chimento MF, Curcio CA.
|
| Invest Ophthalmol Vis Sci 47(7):3119-28. 2006
|
| 13 | APOC3
|
| Susceptibility to type 1 diabetes is associated with ApoCIII gene haplotypes.
|
| Hokanson JE, Kinney GL, Cheng S, Erlich HA, Kretowski A, Rewers M.
|
| Diabetes 55(3):834-8. 2006
|
| 14 | CETP, ABCA1, LPL, APOC3, APOA4
|
| Genetic determinants of plasma HDL-cholesterol levels in familial hypercholesterolemia.
|
| van Aalst-Cohen ES, Jansen AC, Boekholdt SM, Tanck MW, Fontecha MR, Cheng S, Li J, Defesche JC, Kuivenhoven JA, Kastelein JJ.
|
| Eur J Hum Genet 13(10):1137-42. 2005
|
| 15 | APOA1, APOA4, APOA5, APOC3, HLP5
|
| Linkage and association between distinct variants of the APOA1/C3/A4/A5 gene cluster and familial combined hyperlipidemia.
|
| Eichenbaum-Voline S, Olivier M, Jones EL, Naoumova RP, Jones B, Gau B, Patel HN, Seed M, Betteridge DJ, Galton DJ, Rubin EM, Scott J, Shoulders CC, Pennacchio LA.
|
| Arterioscler Thromb Vasc Biol 24(1):167-74. Epub 2003 Oct 09. 2004
|
| 16 | APOC3
|
| Evidence of linkage of HDL level variation to APOC3 in two samples with different ascertainment.
|
| Gagnon F, Jarvik GP, Motulsky AG, Deeb SS, Brunzell JD, Wijsman EM.
|
| Hum Genet 113(6):522-33. Epub 2003 Aug 29. 2003
|
| 17 | APOC3
|
| Interaction between the APOC3 gene promoter polymorphisms, saturated fat intake and plasma lipoproteins.
|
| Brown S, Ordovas JM, Campos H.
|
| Atherosclerosis 170(2):307-13. 2003
|
| 18 | APOA5, APOC3
|
| Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides.
|
| Talmud PJ, Hawe E, Martin S, Olivier M, Miller GJ, Rubin EM, Pennacchio LA, Humphries SE.
|
| Hum Mol Genet 11(24):3039-46. 2002
|
| 19 | APOC3
|
| Linkage of the apo CIII microsatellite with isolated low high-density lipoprotein cholesterol.
|
| Devlin CM, et al.
|
| Hum Genet 102 : 273-281. 1998
|
| 20 | ST3, APOC3, CASP1, FDX1
|
| A yeast artificial chromosome contig and NotI restriction map that spans the tumor suppressor gene(s) locus, 11q22.2-q23.3.
|
| Arai Y, et al.
|
| Genomics 35 : 196-206. 1996
|
| 21 | APOC3
|
| Apolipoprotein C-III (Lys58-Glu). Identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemia.
|
| von Eckardstein A, et al.
|
| J Clin Invest 87 : 1724-1731. 1991
|
| 22 | APOC3
|
| Hypervariable polymorphism in the APOC3 gene.
|
| Bhattacharya S, et al.
|
| Nucleic Acids Res 19 : 4799. 1991
|
| 23 | APOC3
|
| MicroVNTR (CTTT)n at the apo C-III locus.
|
| Hata A, et al.
|
| Nucleic Acids Res 19 : 5098. 1991
|
| 24 | APOC3
|
| Detection of Sstl restriction site polymorphism in human APOC3 by the polymerase chain reaction.
|
| Hixson JE, et al.
|
| Nucleic Acids Res 19 : 196. 1991
|
| 25 | APOC3
|
| Tetranucleotide repeat polymorphism in the apolipoprotein C-III gene.
|
| Zuliani G, et al.
|
| Nucleic Acids Res 18 : 4299. 1990
|
| 26 | APOC3
|
| PvuII polymorphic site upstream to the human ApoCIII gene.
|
| Oettgen P, et al.
|
| Nucleic Acids Res 14 : 5571. 1986
|
| 27 | APOC3
|
| Linkage studies on familial hyperlipoproteinemia with scanthomatosis: normal lipoprotein markers and the C3 polymorphism.
|
| Berg K, et al.
|
| Cytogenet Cell Genet 12 : 266-270. 1976
|